title: Advances in hemophilia care: report of two symposia at the Hemophilia 2010 World Congress.
abstract: The World Federation of Hemophilia (WFH) 2010 World Congress held in Buenos Aires, Argentina, in July 2010, attracted more than 4,300 participants from 106 countries. This report summarizes two symposia held during the congress. The first, titled "Emerging Co-Morbidities in the Aging Hemophilia Population: Healthcare Challenges and Treatment Opportunities," chaired by Gerry Dolan, MD, and Jussara Almeida Cruz, MD, examined the co-morbidities experienced by the aging hemophilic patient population, such as cardiovascular disease, cancer, arthritis, osteoporosis, hypertension, and obesity. In addition, Bayer's products in preclinical and clinical development were reviewed, including a novel factor VIIa variant and a long-acting factor VIII molecule, i.e., one that has undergone site-specific PEGylation (attachment of polyethylene glycol [PEG] polymer chains to another molecule). The other symposium, titled "Practical Steps to Making Better Care for Hemophilia Patients a Reality," chaired by Carmen Altisent, MD, and Cesar Guerrero, RN, reviewed the steps that hemophilia caregivers can take to improve the care of their patients. Issues such as the treatment of hemarthroses, the role of the research nurse, and the management of pediatric patients transitioning to adulthood were discussed.
authors.affiliation: Nottingham Haemophilia Comprehensive Care Centre, University Hospital, Queen's Medical Centre, Derby Road, Nottingham, NG7 2UH, UK. Gerry.Dolan@nottingham.ac.uk
authors.forename: Gerry
authors.initials: G
authors.lastname: Dolan
authors.forename: Jussara Almeida
authors.initials: JA
authors.lastname: Cruz
authors.forename: Elisabeth
authors.initials: E
authors.lastname: Steinhagen-Thiessen
authors.forename: Craig
authors.initials: C
authors.lastname: Kessler
authors.forename: Jesper
authors.initials: J
authors.lastname: Haaning
authors.forename: Georg
authors.initials: G
authors.lastname: Lemm
authors.forename: Carmen
authors.initials: C
authors.lastname: Altisent
authors.forename: Caesar
authors.initials: C
authors.lastname: Guerrero
authors.forename: Cedric
authors.initials: C
authors.lastname: Hermans
authors.forename: Brenda
authors.initials: B
authors.lastname: Riske
authors.forename: Paula
authors.initials: P
authors.lastname: Bolton-Maggs
mesh_terms: D000293:Adolescent; D000368:Aged; D001779:Blood Coagulation Factors / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use; D015897:Comorbidity; D055808:Drug Discovery; D015577:Geriatric Assessment; D014943:Global Health; D006395:Hemarthrosis / Q000628:therapy; D006467:Hemophilia A / Q000188:drug therapy / Q000453:epidemiology / Q000628:therapy*; D006801:Humans; D008017:Life Expectancy; D011994:Recombinant Proteins / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use; D060305:Transition to Adult Care
chemical_list: D001779:Blood Coagulation Factors; D011994:Recombinant Proteins